Literature DB >> 7517946

Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters.

P Kopp1, E T Kimura, S Aeschimann, M Oestreicher, A Tobler, M F Fey, H Studer.   

Abstract

Although somatic mutations have been identified in a subset of thyroid nodules, the pathogenesis of nodules in multinodular goiters remains unclear. Clonal analysis indicates whether a nodule arises from the polyclonal proliferation of a group of cells or forms a clone from a genetically altered cell. Individual thyroid nodules have been shown to be of polyclonal or monoclonal origin. In this study we examined the clonality of several different nodules in patients with multinodular goiters. Clonality was established using the X-chromosomal probe M27 beta, which detects a multiallelic polymorphism at the locus DXS255 in 90% of females. Twenty-five nodules from 9 multinodular goiters were analyzed; 9 nodules were polyclonal, and 16 were monoclonal. Three goiters contained only polyclonal nodules, whereas 3 contained only monoclonal nodules. Polyclonal and monoclonal nodules coexisted in 3 goiters. In 2 goiters, the monoclonal nodules were shown to derive from different progenitor cells. We conclude that polyclonal and monoclonal nodules may coexist in multinodular goiters and that monoclonal nodules can originate from different cells. The coexistence of polyclonal and monoclonal nodules suggests that different pathogenic mechanisms occur simultaneously or that monoclonal nodules emerge secondarily from a polyclonal population due to a growth advantage from a genetically altered cell.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517946     DOI: 10.1210/jcem.79.1.7517946

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Mixed medullary and follicular carcinoma of the thyroid. On the search for its histogenesis.

Authors:  X Matias-Guiu
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Clonality in Thyroid Nodules: The Hyperplasia-Neoplasia Sequence.

Authors:  Zubair W. Baloch; Virginia A. LiVolsi
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

Review 4.  Molecular rearrangements and morphology in thyroid cancer.

Authors:  Todd G Kroll
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 5.  Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.

Authors:  Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

Review 6.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

7.  Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.

Authors:  P Kopp; S Muirhead; N Jourdain; W X Gu; J L Jameson; C Rodd
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

8.  Non-hyperfunctioning nodules from multinodular goiters: a minor role in pathogenesis for somatic activating mutations in the TSH-receptor and Gsalpha subunit genes.

Authors:  C Derrien; E Sonnet; I Gicquel; J Y Le Gall; J Y Poirier; V David; D Maugendre
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

9.  Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal.

Authors:  P Harrer; M Broecker; A Zint; H Schatz; V Zumtobel; M Derwahl
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

Review 10.  My approach to oncocytic tumours of the thyroid.

Authors:  S L Asa
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.